Pharmaceutical industry giants have long been suspected as not playing a fair hand with the American public. As Congress struggles to retain a new health care system that is facing an uphill battle in the courts system, the future of health care and in particular pharmaceuticals is uncertain. But with more whistleblowers coming out of the woodwork than ever before, it is safe to say that no matter what happens with the final decision on health care, pharmaceuticals will be placed under intense scrutiny.